Geoff Meacham
Stock Analyst at Citigroup
(3.70)
# 778
Out of 4,915 analysts
257
Total ratings
55.56%
Success rate
4.99%
Average return
Main Sectors:
Stocks Rated by Geoff Meacham
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTCT PTC Therapeutics | Maintains: Neutral | $40 → $50 | $50.94 | -1.85% | 9 | Jul 28, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $79 → $78 | $57.68 | +35.23% | 3 | Jul 22, 2025 | |
| RPRX Royalty Pharma | Maintains: Buy | $40 → $42 | $37.12 | +13.15% | 3 | Jul 22, 2025 | |
| AMGN Amgen | Maintains: Neutral | $300 → $305 | $301.37 | +1.20% | 12 | Jul 22, 2025 | |
| BBIO BridgeBio Pharma | Maintains: Buy | $50 → $54 | $45.62 | +18.37% | 6 | Jun 25, 2025 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $72 | $54.62 | +31.82% | 1 | Jun 17, 2025 | |
| NAMS NewAmsterdam Pharma Company | Initiates: Buy | $42 | $22.42 | +87.37% | 1 | Jun 17, 2025 | |
| ACLX Arcellx | Initiates: Buy | $110 | $71.48 | +53.90% | 1 | Jun 17, 2025 | |
| AMLX Amylyx Pharmaceuticals | Initiates: Buy | $12 | $7.97 | +50.56% | 2 | Jun 17, 2025 | |
| ABOS Acumen Pharmaceuticals | Initiates: Buy | $4 | $1.46 | +173.97% | 4 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $6 | $6.85 | -12.41% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $75 | $36.88 | +103.36% | 6 | Jun 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $700 → $650 | $554.58 | +17.21% | 22 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $210 → $205 | $189.31 | +8.29% | 17 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $47 → $44 | $44.07 | -0.16% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $140 | $110.05 | +27.21% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $7 → $1 | $2.08 | -51.92% | 3 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $40 | $32.15 | +24.42% | 10 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $30.06 | +33.07% | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $37.61 | +152.59% | 2 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $9.53 | +162.47% | 1 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $99 → $103 | $58.81 | +75.14% | 3 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $160 → $145 | $126.64 | +14.50% | 14 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $112 → $4 | $1.43 | +179.72% | 5 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $114.76 | +8.92% | 6 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $575 | $469.16 | +22.56% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,150 → $1,100 | $760.08 | +44.72% | 9 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $120 → $20 | $12.44 | +60.77% | 3 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $31 | $11.15 | +178.03% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $0.35 | +2,757.96% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $145 | $81.75 | +77.37% | 6 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $167.26 | +1.64% | 3 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $48 | $24.23 | +98.10% | 2 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $68 → $60 | $45.98 | +30.49% | 8 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 | $1.26 | +534.92% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $23 → $14 | $5.24 | +167.18% | 2 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $10 → $8 | $5.42 | +47.60% | 4 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $17 | $0.55 | +3,007.29% | 1 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $50 → $45 | $23.81 | +89.00% | 6 | Apr 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $24 | $1.44 | +1,566.67% | 4 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $4 | $3.85 | +3.90% | 2 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $1.55 | +1,712.30% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $0.57 | +5,871.20% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $4.79 | +1,069.10% | 3 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $35 | $1.41 | +2,382.27% | 4 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $525 | $3.32 | +15,713.25% | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $1.43 | +2,837.06% | 1 | Oct 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $7.91 | +152.84% | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $0.55 | +3,569.72% | 2 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Underperform | $9 | $3.16 | +184.81% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $60 | $8.75 | +585.71% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7 | $3.97 | +76.32% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $23 | $12.94 | +77.74% | 3 | Aug 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $90 → $82 | $77.55 | +5.74% | 9 | May 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $100 → $95 | $281.95 | -66.31% | 6 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $300 → $80 | $9.21 | +768.62% | 3 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $135 | $136.76 | -1.29% | 2 | Aug 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $6.86 | - | 4 | May 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $20 | $0.83 | +2,300.67% | 4 | May 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $15.60 | - | 2 | Apr 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $127 → $158 | $339.80 | -53.50% | 5 | Nov 8, 2017 |
PTC Therapeutics
Jul 28, 2025
Maintains: Neutral
Price Target: $40 → $50
Current: $50.94
Upside: -1.85%
CRISPR Therapeutics AG
Jul 22, 2025
Maintains: Buy
Price Target: $79 → $78
Current: $57.68
Upside: +35.23%
Royalty Pharma
Jul 22, 2025
Maintains: Buy
Price Target: $40 → $42
Current: $37.12
Upside: +13.15%
Amgen
Jul 22, 2025
Maintains: Neutral
Price Target: $300 → $305
Current: $301.37
Upside: +1.20%
BridgeBio Pharma
Jun 25, 2025
Maintains: Buy
Price Target: $50 → $54
Current: $45.62
Upside: +18.37%
Protagonist Therapeutics
Jun 17, 2025
Initiates: Buy
Price Target: $72
Current: $54.62
Upside: +31.82%
NewAmsterdam Pharma Company
Jun 17, 2025
Initiates: Buy
Price Target: $42
Current: $22.42
Upside: +87.37%
Arcellx
Jun 17, 2025
Initiates: Buy
Price Target: $110
Current: $71.48
Upside: +53.90%
Amylyx Pharmaceuticals
Jun 17, 2025
Initiates: Buy
Price Target: $12
Current: $7.97
Upside: +50.56%
Acumen Pharmaceuticals
Jun 17, 2025
Initiates: Buy
Price Target: $4
Current: $1.46
Upside: +173.97%
Jun 17, 2025
Initiates: Sell
Price Target: $6
Current: $6.85
Upside: -12.41%
Jun 10, 2025
Maintains: Buy
Price Target: $70 → $75
Current: $36.88
Upside: +103.36%
Jun 2, 2025
Maintains: Buy
Price Target: $700 → $650
Current: $554.58
Upside: +17.21%
May 14, 2025
Downgrades: Neutral
Price Target: $210 → $205
Current: $189.31
Upside: +8.29%
May 12, 2025
Maintains: Neutral
Price Target: $47 → $44
Current: $44.07
Upside: -0.16%
May 6, 2025
Maintains: Buy
Price Target: $145 → $140
Current: $110.05
Upside: +27.21%
Apr 2, 2025
Downgrades: Underperform
Price Target: $7 → $1
Current: $2.08
Upside: -51.92%
Mar 13, 2025
Initiates: Neutral
Price Target: $40
Current: $32.15
Upside: +24.42%
Mar 13, 2025
Initiates: Buy
Price Target: $40
Current: $30.06
Upside: +33.07%
Mar 13, 2025
Initiates: Buy
Price Target: $95
Current: $37.61
Upside: +152.59%
Mar 13, 2025
Initiates: Buy
Price Target: $25
Current: $9.53
Upside: +162.47%
Feb 20, 2025
Maintains: Buy
Price Target: $99 → $103
Current: $58.81
Upside: +75.14%
Feb 13, 2025
Maintains: Neutral
Price Target: $160 → $145
Current: $126.64
Upside: +14.50%
Jan 7, 2025
Downgrades: Underperform
Price Target: $112 → $4
Current: $1.43
Upside: +179.72%
Nov 14, 2024
Initiates: Buy
Price Target: $125
Current: $114.76
Upside: +8.92%
Nov 14, 2024
Initiates: Buy
Price Target: $575
Current: $469.16
Upside: +22.56%
Oct 31, 2024
Maintains: Buy
Price Target: $1,150 → $1,100
Current: $760.08
Upside: +44.72%
Oct 30, 2024
Downgrades: Underperform
Price Target: $120 → $20
Current: $12.44
Upside: +60.77%
Oct 18, 2024
Upgrades: Buy
Price Target: $22 → $31
Current: $11.15
Upside: +178.03%
Aug 19, 2024
Maintains: Buy
Price Target: $12 → $10
Current: $0.35
Upside: +2,757.96%
Jul 31, 2024
Maintains: Buy
Price Target: $150 → $145
Current: $81.75
Upside: +77.37%
Apr 17, 2024
Maintains: Neutral
Price Target: $180 → $170
Current: $167.26
Upside: +1.64%
Mar 13, 2024
Maintains: Buy
Price Target: $24 → $48
Current: $24.23
Upside: +98.10%
Jan 3, 2024
Downgrades: Neutral
Price Target: $68 → $60
Current: $45.98
Upside: +30.49%
Dec 15, 2023
Downgrades: Neutral
Price Target: $8
Current: $1.26
Upside: +534.92%
Sep 8, 2023
Downgrades: Neutral
Price Target: $23 → $14
Current: $5.24
Upside: +167.18%
Aug 21, 2023
Maintains: Underperform
Price Target: $10 → $8
Current: $5.42
Upside: +47.60%
Aug 21, 2023
Maintains: Buy
Price Target: $19 → $17
Current: $0.55
Upside: +3,007.29%
Apr 21, 2023
Maintains: Neutral
Price Target: $50 → $45
Current: $23.81
Upside: +89.00%
Nov 1, 2022
Downgrades: Underperform
Price Target: $24
Current: $1.44
Upside: +1,566.67%
Jun 8, 2022
Downgrades: Neutral
Price Target: $12 → $4
Current: $3.85
Upside: +3.90%
Aug 10, 2021
Initiates: Buy
Price Target: $28
Current: $1.55
Upside: +1,712.30%
Jul 13, 2021
Initiates: Buy
Price Target: $34
Current: $0.57
Upside: +5,871.20%
May 7, 2021
Upgrades: Buy
Price Target: $56
Current: $4.79
Upside: +1,069.10%
Jan 15, 2021
Downgrades: Neutral
Price Target: $35
Current: $1.41
Upside: +2,382.27%
Nov 23, 2020
Initiates: Buy
Price Target: $525
Current: $3.32
Upside: +15,713.25%
Oct 20, 2020
Initiates: Buy
Price Target: $42
Current: $1.43
Upside: +2,837.06%
Sep 15, 2020
Reinstates: Buy
Price Target: $20
Current: $7.91
Upside: +152.84%
Sep 8, 2020
Reinstates: Buy
Price Target: $20
Current: $0.55
Upside: +3,569.72%
Jun 25, 2020
Reinstates: Underperform
Price Target: $9
Current: $3.16
Upside: +184.81%
Jun 25, 2020
Reinstates: Buy
Price Target: $60
Current: $8.75
Upside: +585.71%
Jun 25, 2020
Initiates: Underperform
Price Target: $7
Current: $3.97
Upside: +76.32%
Aug 5, 2019
Maintains: Equal-Weight
Price Target: $15 → $23
Current: $12.94
Upside: +77.74%
May 3, 2019
Downgrades: Equal-Weight
Price Target: $90 → $82
Current: $77.55
Upside: +5.74%
Mar 1, 2019
Maintains: Underweight
Price Target: $100 → $95
Current: $281.95
Upside: -66.31%
Dec 20, 2018
Downgrades: Equal-Weight
Price Target: $300 → $80
Current: $9.21
Upside: +768.62%
Aug 1, 2018
Maintains: Overweight
Price Target: $100 → $135
Current: $136.76
Upside: -1.29%
May 21, 2018
Downgrades: Underweight
Price Target: n/a
Current: $6.86
Upside: -
May 3, 2018
Maintains: Equal-Weight
Price Target: $16 → $20
Current: $0.83
Upside: +2,300.67%
Apr 5, 2018
Downgrades: Equal-Weight
Price Target: n/a
Current: $15.60
Upside: -
Nov 8, 2017
Maintains: Overweight
Price Target: $127 → $158
Current: $339.80
Upside: -53.50%